Triple Negative Breast Cancer Clinical Trials
Triple negative breast cancer clinical trials are important research studies that evaluate the effectiveness of new medical approaches for treating patients with any stage of breast cancer. These studies serve as an essential means of transferring new scientific discoveries regarding the prevention, diagnosis and treatment of cancer out of the laboratories and into physicians’ offices, where patients can immediately benefit from them.
At Moffitt Cancer Center, our goal is to present our patients with the best possible treatment options. Each patient’s case is studied in depth by our multispecialty tumor board of experts who collaboratively formulate a recommended treatment approach. While each patient is unique, we often recommend participation in clinical trials any time a patient is faced with a treatment decision (if an appropriate trial is available and the patient qualifies for participation). As medical researchers continue to work to improve current breast cancer treatments and evaluate new and better approaches, a clinical trial can have an important place in a patient’s treatment plan. Here are some of the reasons that a patient might consider participating in triple negative breast cancer clinical trials:
- Even though there may be a current standard of care for treating a patient’s specific diagnosis, newer and more effective treatment options that are suitable for the patient may be available, but only through clinical trials.
- Sometimes, the standard of care works well for a patient initially, but then loses its effectiveness over time, and a new treatment approach proves beneficial.
- There may be no existing standard of care that is appropriate for treating a certain patient’s condition, but the patient may be able to benefit from new approaches being evaluated in clinical trials.
At Moffitt, some of the country’s most renowned cancer experts and scholars have come together to ensure that our programs continue to achieve the greatest impact possible for both current and future cancer patients. As the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, Moffitt is well-recognized for its role in shaping the future of cancer treatment.
To learn about the triple negative breast cancer clinical trials currently underway at Moffitt Cancer Center, call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online.